GlobeNewswire

Aino Health AB (publ): Aino Health year-end report January-December 2020

Share

This document in English is a translation of the original in Swedish. In case of any discrepancy, the Swedish original will prevail.

February 2, 2021 

Focus on Sweden to meetincreasedneeds,SaaS subscription levels steady compared to last year


October – December 2020 

  • Net sales were KSEK 7 132 (8 201) * 
  • Profit after financial items increased to KSEK -2 648 (-3 676) 
  • Earnings per share were SEK -0.1 (-0.2) 

January – December 2020 

  • Net sales were KSEK 24 916 (25 873) * 
  • Profit after financial items increased to KSEK -13 166 (-15 273) 
  • Earnings per share were -0.7 (-1.0) 

* At the end of Q4 2020, the company had about MSEK 2.1 in accounts receivable from result-based contracts, accrued during Q42018–Q12020, of which SEK 2 million have been recognized as revenue during Q4 2019 and Q4 2020. For more information, see page 5 in the report. 


During the last quarter of the year, we could see that the sales situation caused by COVID-19 improved somewhat and we could once again book client meetings in Finland and Sweden. This resulted in an expanded contract with Transcom, through which they will be implementing HealthManager at all sites in Sweden. We also signed a new client contract with the Swedish assistance company Curira, which is our first healthcare client in Sweden. 

The decrease in net sales is due to delayed delivery of some services because of COVID-19 and changes in exchange rates. The EBITDA has developed positively due to cost control. 

A focus on Sweden to meet increased needs 

As we look ahead and enter 2021, we have – due to the current situation – chosen to focus on the Swedish market. We have a strong momentum here and need to meet the increased needs.  

We continue to invest some of the capital provided during the fall to expand and reinforce our sales organisation in Sweden. This is done in part through recruitment and in part through increasing sales capacity through outsourcing.   

SaaS subscriptions increasing 

As of December 31, we have around 49 000 subscriptions. 

I look forward to 2021 with confidence. We have many activities ongoing that will further improve our ability to help existing and potential clients keep their employees healthy and committed using digital processes and best practices from Aino. 

Jyrki Eklund

CEO and President  
Aino Health AB 


The information contained herein is such as shall be made public by Aino Health AB (publ), in accordance with the EU Market Abuse Regulation. This information was made public, through the agency of Jyrki Eklund, CEO and President of Aino Health AB, at 08.30 AM CET on February 2, 2021.


F
or more information:

Jyrki Eklund, CEO Aino Health
Phone: +358 40 042 4221

Certified adviser 

Erik Penser Bank
+46 8 463 83 00
certifiedadviser@penser.se 

About Aino Health (publ) 

Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq First North Growth Market (Ticker: AINO). 
For more information: https://investors.ainohealth.com/en

Attachments


About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

AMG Advanced Metallurgical Group N.V. Reports Full Year and Fourth Quarter 2020 Results24.2.2021 18:00:00 CETPress release

Coronavirus Update As of today, out of over 3,000 employees we have 3 active confirmed coronavirus cases globally. AMG has zero current COVID hospitalization cases. AMG has not experienced any coronavirus related fatalities, and our current cases have not resulted in a facility closure or operational interruption. AMG continues to implement preventive measures such as practicing social distancing, remote working when possible, and restrictions on travel to protect the health and safety of our employees. Strategic Highlights The construction of AMG’s second ferrovanadium plant in Zanesville, Ohio is proceeding as planned. As of December 31, 2020, AMG has committed $206 million in construction and engineering contracts for the project.AMG Brazil has entered into an Exclusive Cooperation Agreement (“ECA”) with one of its major customers for lithium concentrates. The ECA provides for AMG Brazil to supply 200,000 DMT over a 5-year supply term, which will be obtained from an expansion (targe

Golar LNG Partners LP Common Unitholders Approve Merger at Special Meeting24.2.2021 17:55:15 CETPress release

Golar LNG Partners LP announces that at a special meeting held today, the holders of common units representing limited partner interests of Golar LNG Partners LP (Nasdaq: GMLP) (“GMLP”) voted on and approved the Agreement and Plan of Merger (the “Merger Agreement”), dated as of January 13, 2021, by and among GMLP, Golar GP LLC, New Fortress Energy Inc. (“NFE”), Lobos Acquisition LLC and NFE International Holdings Limited, and the merger contemplated thereby (the “Merger”). Pursuant to the Merger Agreement NFE has agreed to acquire all of the outstanding common units and general partner units of GMLP for $3.55 per unit in cash. The Merger is expected to close in the first half of 2021. As previously announced, the closing of the merger is conditioned upon receipt of a number of approvals and consents. FORWARD-LOOKING STATEMENTS This press release contains certain forward-looking statements concerning future events. Forward-looking statements include, without limitation, any statement th

LIDDS files patent application for method to treat brain cancer with intratumoral depot injections24.2.2021 17:19:34 CETPress release

UPPSALA, SWEDEN – LIDDS AB (publ) announced today that a patent application related to NanoZolid® for treatment of brain cancers was filed to the European patent office. The patent application relates to a method to treat brain cancer with intratumoral depots providing a controlled drug release at the tumor site. Advances in treatments of malignant brain tumors have only modestly improved survival rates of patients. LIDDS can with the NanoZolid® technology expand its platform to brain cancer by circumventing the blood-brain barrier and to increase the drug distribution within the tumor area. “It is with excitement that we file a patent in this important area with a large unmet medical need,” said Monica Wallter, CEO of LIDDS. “Our favorable preclinical results on the NanoZolid® carrier in brain tissue, together with the drug release characteristics that we can obtain with our technology, form the basis for this invention. I am hopeful that this development and potential commercializati

SEK TENDER OPERATION ANNOUNCEMENT FOR ONWARD LENDING24.2.2021 16:20:00 CETPress release

Bid date, 2021-02-26Bid Submission Date2021-02-26Bid times10.30-11.00 (CET/CEST) on the Bid dateOffered Amount50 billion SEKMaximum Permitted Bid Volume12.5 billion SEK from an individual bidderSettlement Date2021-03-02Minimum Permitted Bid Volume10 million SEK per bidFinal Repayment Date2025-03-03Maximum Allocation25 per cent of Offered AmountAllocation TimeNot later than 11.30 (CET/CEST) on the Bid dateRepayment Date2022-03-02Option Repayment Date 12023-03-02Option Repayment Date 22024-03-04Interest rateThe Riksbank´s applicable repo rateAdditional interest rate0.10 per centConfirmation of bids to e-maileol@riksbank.se Stockholm, 2021-02-24 This is a translation of the special terms and conditions published on www.riksbank.se. In the case of any inconsistency between the English translation and the Swedish language version, the Swedish language version shall prevail. Complete terms and conditions can be retrieved at www.riksbank.se.

JETEX MAKES FLYING WITH A REDUCED CARBON FOOTPRINT POSSIBLE24.2.2021 12:45:47 CETPress release

Dubai, United Arab Emirates, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Jetex customers are now able to choose to fly with a reduced carbon footprint from six key global locations following an agreement with Shell. This demonstrates how general aviation service providers can support the International Air Transport Association (IATA) and its commitment to reducing the industry’s carbon emissions by 50% by 2050. Jetex, an award-winning global leader in executive aviation, is fully aware of its responsibility towards the natural environment and to future generations, and pursues a comprehensive environmental strategy. In today’s world, private aviation is a vital global catalyst for growth, providing access to markets, supporting jobs and promoting travel recovery. In addition to its many positive economic effects, though, air transport contributes to the production of carbon emissions. In response, Jetex is working with Shell to offer customers an option to offset the carbon emissions of their ai

Olainfarm invites to Fourth Quarter 2020 Investor Conference Webinar24.2.2021 10:13:00 CETPress release

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on March 2, 2020 at 04:00 PM (EET). To join the webinar please follow the instructions below. Webinar will be hosted by the Chairman of Management Board Jeroen Weites and member of the management board Zane Kotāne. The presentation will be held in English. During the webinar JSC Olainfarm representatives will inform about the recent performance of the company and financial results of fourth quarter of 2020 and 12 months of 2020. After the presentation investors are welcome to ask questions. Due to the limited webinar time please send in your questions until March 1 to e-mail: marta.muizniece@nasdaq.com. What is a webinar? Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questi